RCT | Rapid up-titration of guideline-directed medical therapies for acute heart failure reduced readmissions and deaths.

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial – The Lancet (free registration required)

News Release: Maximizing heart failure meds within 2 weeks reduced risk of hospital readmission, death – American Heart Association

Commentary: STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends – TCTMD